Beta Thalassemia HBB Full Gene Analysis (Single) in UAE | 1000 AED | 2026 DHA Guidelines

تحليل جين HBB الكامل لبيتا ثلاسيميا (فحص جيني مفرد) في الإمارات | 1000 درهم | معتمد من هيئة الصحة بدبي

Executive Summary
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 accredited, DHA-compliant Sanger Sequencing. Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection; VIP Mobile Phlebotomy available 8 AM – 11 PM daily. Clinical Guidance: Complimentary telephonic post‑test clinical guidance from our medical team. Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.

الملخص التنفيذي: ضمان دقة تشخيصية بنسبة 99.9% عبر تسلسل سانغر المعتمد من الأيزو 9001:2015 وهيئة الصحة بدبي. خدمة سحب منزلي فاخرة بمستوى المستشفيات مع سلسلة تبريد معتمدة، وفريق طبي متنقل من الساعة 8 صباحاً حتى 11 مساءً. استشارة طبية هاتفية بعد النتيجة مجاناً. التحقق المباشر من تغطية التأمين عبر واتساب +971 54 548 8731.

Pre‑Test Requirement (DHA/ MOHAP Standard): A doctor’s prescription is required. Exemptions: Prescription is not required for surgery, pregnancy, or individuals planning to travel abroad. All samples are processed in a facility licensed under No. 9834453.

Test Overview

Beta Thalassemia HBB Full Gene Analysis (Single) determines the complete DNA sequence of the beta‑globin gene using gold‑standard Sanger chemistry, detecting all clinically significant point mutations, small deletions, and splice‑site variants. يشمل هذا الفحص تحليل التسلسل الكامل للجين HBB لتحديد الطفرات المسببة لمرض بيتا ثلاسيميا بدقة شاملة.

Feature	Our Test (Full Gene Sanger)	Closest Alternative (Targeted Mutation Panel PCR)
Diagnostic Precision	Identifies all pathogenic variants across entire gene, including rare familial mutations	Detects only predefined common mutations; may miss up to 15% of causative variants in UAE population
Methodology	Sanger Sequencing (Gold Standard, DHA/MOHAP approved)	ARMS‑PCR or Reverse Dot Blot
Turnaround Time	8–10 working days	5–7 working days

Physician Insight & Clinical Safety Protocol

“This test provides definitive molecular confirmation of beta‑thalassemia carrier status or disease. However, a genetic result must always be interpreted in conjunction with a complete blood count, hemoglobin electrophoresis, and family history. I urge every patient to discuss their report with a specialist hematologist or clinical geneticist before making any reproductive or therapeutic decisions.”

— Dr. Prabhakar Reddy, Consultant Clinical Pathologist (DHA License: 61713011)

⚠️ Medication Warning

Do not discontinue prescribed medication (e.g., iron chelators, folic acid) without consulting your doctor. Genetic results do not replace ongoing clinical management.

Patient Safety: Exclusion Criteria & Emergency Red Flags

Exclusion Criteria: Active, uncontrolled bleeding disorder; severe anemia (Hb < 7 g/dL) requiring immediate transfusion; inability to provide informed consent. Patients with known severe hemophilia must inform the phlebotomist before sample collection.
Emergency Red Flags: If you experience sudden severe pallor, fainting, shortness of breath at rest, or chest pain after blood draw, seek emergency medical attention immediately. This test is not for self‑diagnosis; interpretation requires a licensed physician.
Data Privacy: All genetic data is protected under UAE PDPL and Federal Decree‑Law No. 41 of 2024 (Art. 87). Minor testing follows CDS Law 2026.

Patient FAQs & Clinical Guidance

1. How is full gene analysis different from a targeted mutation panel?

Full gene sequencing by Sanger covers all coding regions and splice sites, ensuring no rare mutation is missed, unlike panels that only check common variants. يغطي التحليل الكامل جميع مناطق التشفير والمواقع الواصلة، فلا يفوت أي طفرة نادرة بخلاف الفحوصات المحدودة.

2. Is this test suitable for prenatal carrier screening?

Yes, this is the definitive for couples planning pregnancy; it identifies both common and rare HBB mutations vital for genetic counseling. نعم، هو الفحص القاطع للأزواج قبل الحمل، ويحدد الطفرات الشائعة والنادرة اللازمة للاستشارة الوراثية.

3. What does the 8‑10 day turnaround time include?

The timeline covers sample transport, DNA extraction, Sanger sequencing, bioinformatics analysis, and a double‑reviewed clinical report written by our consultants. تشمل المدة نقل العينة واستخلاص الحمض النووي والتسلسل الجيني والتحليل المعلوماتي وتقرير طبي مزدوج المراجعة.

Laboratory Facility License No. 9834453 | ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139) | All services comply with UAE Federal Decree‑Law No. 41 of 2024 (Art. 87), CDS Law 2026 (Minors), and UAE PDPL. WhatsApp Support: +971545488731.

دعم ثنائي اللغة متاح